Chronic Kidney Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged range from 18 to 90 years, no gender limit; 2. Patients diagnosed with hemodialysis; 3. Patient 28g/L<= serum albumin <=40g/L or prealbumin <=150mg/L; 4. The patient met the diagnosis of sarcopenia (walk test <0.8m/s, grip strength <25kg in men and <18kg in women or relative skeletal muscle mass index RSMI less than 7.26kg/m^2 in men and 5.45 kg/m^2 in women); 5. Be able to understand the purpose of the trial, participate voluntarily and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergic to the ingredients contained in the research supplies; 2. Suffering from other serious systemic diseases (such as cardiovascular, respiratory, digestive, nervous, endocrine, reproductive or other urinary system diseases, tumors, etc.); 3. Patients who suffer from mental illness, including severe hysteria, and do not have autonomous ability; 4. A history of substance abuse or alcoholism; 5. Participate in other drug clinical trials within 30 days prior to this study; 6. The researcher judged that the patient had poor compliance and could not complete the study as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| albumin;prealbumin;IL-1;IL-6;TNF-a;body composition;the power of gripping; | — |
Secondary
| Measure | Time frame |
|---|---|
| liver function: ALT, AST; | — |
Countries
China
Contacts
Shanghai Changhai Hospital